Immediate Impact
3 from Science/Nature 70 standout
Citing Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Emerging therapies in cancer metabolism
2023 Standout
Works of Michael Goodman being referenced
Phase 2 study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients (pts) with progressive metastatic castrate-resistant prostate cancer (mCRPC).
2023
International Variations in Bladder Cancer Incidence and Mortality
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Goodman | 253 | 119 | 309 | 149 | 30 | 792 | |
| J-E Johansson | 189 | 180 | 156 | 83 | 32 | 708 | |
| Bent L. Sørensen | 126 | 153 | 390 | 83 | 26 | 678 | |
| Jens B. Knudsen | 127 | 156 | 401 | 67 | 20 | 789 | |
| Rajeev Sinha | 192 | 117 | 273 | 70 | 40 | 685 | |
| Donald I. Moel | 133 | 113 | 142 | 191 | 34 | 928 | |
| C. K. Anderson | 152 | 114 | 244 | 157 | 39 | 727 | |
| J Staszewski | 157 | 255 | 118 | 71 | 25 | 665 | |
| B. Richards | 297 | 169 | 355 | 129 | 38 | 925 | |
| L. K. Heilbrun | 411 | 262 | 148 | 190 | 18 | 852 | |
| A.‐C. Teger‐Nilsson | 288 | 40 | 187 | 80 | 37 | 922 |
All Works
Login with ORCID to disown or claim papers
Loading papers...